| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31dee1c5d9637d58af289c5fe5a6fc01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31220186fc39afa444f4583a87053d05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_165926d5404a5392390126b3fdf42a38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47733cb9741104f88c664a73274f4f8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef416fe4f66ebb1021cecfb0ba5ae45d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db61b6c9ac751b79b5e22126a4eef181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7981709e59293dfd53561afecdb787e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate |
2004-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fb7554e7a3771fb9bd3d17e383b8746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50c5fec3ef99bd2f4d7a343e8e5db29c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31b9c81f46de48d47a1d0a9a241195b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3de4a91e1440cb62728137224a963ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c19489213f773fe381aa6fe084557ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3e02fea2ff76aff9b6ec7e32014dc0f |
| publicationDate |
2011-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8084041-B2 |
| titleOfInvention |
Use of mycrobacterial vaccines in CD4+ or CD8+ lymphocyte-deficient mammals |
| abstract |
Methods of treating a mammal that is deficient in CD4 + and/or CD8 + lymphocytes are provided. The methods comprise inoculating the mammal with an attenuated mycobacterium in the M. tuberculosis complex. In these methods, the mycobacterium comprises two deletions, wherein a virulent mycobacterium in the M. tuberculosis complex having either deletion exhibits attenuated virulence. Use of these mycobacteria for the manufacture of a medicament for the treatment of mammals deficient in CD4 + and/or CD8 + lymphocytes is also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9637749-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013170154-A1 |
| priorityDate |
2003-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |